Anxiety and depression are common struggles for many living with chronic pain. In fact, recent research indicates that around 40% of adults experiencing chronic pain also show clinical symptoms of anxiety or depression. Those with conditions like fibromyalgia, younger adults, and women are especially vulnerable to emotional distress.
A new study suggests that medical cannabis, particularly products rich in tetrahydrocannabinol (THC), could serve as a promising alternative to traditional antidepressants and anti-anxiety medications such as Xanax.
Published recently in the Journal of Affective Disorders, this observational study found that both people with and without chronic pain experienced meaningful and lasting reductions in anxiety and depression after starting medicinal cannabis.
Researchers from Johns Hopkins University School of Medicine and La Trobe University tracked 33 participants in Maryland over six months. The volunteers completed assessments of their anxiety and depression levels before starting cannabis use and again at one, three, and six months.
Most chose cannabis products high in THC—the compound responsible for cannabis’s psychoactive effects—and experienced notable reductions in anxiety and depression symptoms within three months. The relief was linked to dosage, with participants consuming 10 to 15 milligrams of oral THC or taking at least three puffs of vaporized cannabis reporting the most improvement.
However, some participants noted side effects such as feeling “high,” which at times impaired their ability to drive safely. Despite this, the overall findings were encouraging.
The researchers concluded, “Initiation of THC-dominant medicinal cannabis was associated with immediate reductions in anxiety and depression, as well as sustained decreases in symptom severity over six months. Further controlled clinical trials are necessary to confirm the safety and effectiveness of medicinal cannabis for these conditions.”
This study aligns with earlier research showing that THC plays a critical role in the therapeutic effects of cannabis. A 2019 review of health data from over 3,300 cannabis users revealed that THC outperformed cannabidiol (CBD) alone in easing chronic pain, insomnia, and other health issues. Products with higher THC levels offered the greatest relief.
Additionally, a small study from Israel found that “microdosing” THC—using very small amounts—could significantly reduce neuropathic pain without causing cognitive impairment or other side effects.
Practical Suggestions for Those Considering Medical Cannabis
If you or someone you know is exploring medical cannabis for anxiety or depression, consider starting with low doses of THC under medical supervision. Pay attention to how your body reacts, especially regarding alertness and coordination, to avoid risks like impaired driving. Consulting healthcare professionals familiar with cannabis treatment can help tailor a safe, effective approach.
As research evolves, medicinal cannabis may become a valuable option for managing anxiety and depression, particularly for those with chronic pain who seek alternatives to conventional pharmaceuticals.
Related topics:
Brain Circuit Discovery May Ease Postpartum Depression Symptoms
Why Exercise Alone May Not Boost Your Mental Health
Insomnia May Explain Low Life Satisfaction in Adults with ADHD
